NCT00097877已完成3 期
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 293
- 试验地点
- 74
- 主要终点
- HbA1c
研究概览
简要总结
This trial is conducted in the United States of America (USA). The purpose of this study is to test whether Biphasic Insulin Aspart 70/30 twice a day with Metformin improves glycemic control vs. once daily Insulin Glargine with Metformin in subjects with Type 2 Diabetes who are inadequately controlled on basal insulin plus oral anti-diabetic therapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 Diabetes
排除标准
- 未提供
结局指标
主要结局
HbA1c
时间窗: After 24 weeks
次要结局
- other glycemic variables
- safety variables
- 8-point plasma glucose profile
研究者
研究点 (74)
Loading locations...
相似试验
已完成
4 期
Comparison of Glycemic Control Achieved With 2 Different NeedlesDelivery SystemsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2NCT00572052Novo Nordisk A/S62
已完成
3 期
Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00184574Novo Nordisk A/S603
已完成
4 期
Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once DailyDiabetesDiabetes Mellitus, Type 2NCT00634842Novo Nordisk A/S244
已完成
4 期
Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00807092Novo Nordisk A/S145
已完成
3 期
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00333151Novo Nordisk A/S576